More recent publications show that morphological differentiation and Ki-67 are able to separate prognostic groups among G3 cases and therefore a separation of well-differentiated G3 NET with a Ki67 between 20-50%, from poorly differentiated G3 NEC with a Ki67 between 50-100% is emerging. This evidence concerns the gene MKI67 and neuroendocrine carcinoma.